| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3188856 | Annales de Dermatologie et de Vénéréologie | 2009 | 7 Pages |
Abstract
Because of its high response rates and rapidity of action, TSEB should be considered as first-line therapy in the management of early-stage mycosis fungoides.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
E. Goujon, G. Truc, T. Pétrella, P. Maingon, G. Jeudy, E. Collet, C. Galliot, S. Dalac-Rat,